Imperial College London


Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Clinical and Molecular Haemato-oncology



holger.auner04 Website




Miss Mandy Sale +44 (0)20 3313 4017




4N7ACommonwealth BuildingHammersmith Campus




Guest Lectures

Metabolic mechanisms of resistance., UK Myeloma Forum, UKMF Spring Day, 2019

Introduction to available myeloma therapies and rationale, Oxford University Hospitals, Keble College, Oxford, 2018

Salvage Transplant for Relapse (Multiple Myeloma), EBMT, 44th Annual Meeting, Lisbon, Portugal, 2018

Freiburg Myeloma Workshop (Freiburg, Germany), University of Freiburg, Freiburg, Germany, 2017

Current clinical trial landscape in the UK, 10th Myeloma Workshop and Meeting of the Deutsche Studiengruppe Multiples Myelom, Starnberger See, Germany (C. Straka/H. Einsele), 2017

Myeloma Academy Haematologists‘ Roadshow Debate and Round Table Discussion (London), Myeloma UK, 2016

New Proteasome Inhibitors in Myeloma - UK Myeloma Forum Autumn Day 2016 (London), UK Myeloma Forum, 2016

EBMT Preceptorship “Stem cell transplantation in multiple myeloma” (Turin), EBMT, 2014

Symposium “The elderly haemato-oncological patient” (Hamburg), University Hospital Hamburg Eppendorf, Hamburg, Germany, 2014

EBMT Educational “Treatment option for relapse after autograft in Multiple Myeloma” (Hamburg), EBMT and UKE Hamburg, 2014

EBMT Annual Meeting Chronic Malignancies Working Party Plenary Session (Milan), EBMT, Milan, Italy, 2014

Research Seminar (St. Gallen, Switzerland), Universitaetsklinik St. Gallen, 2012

PhD Guest Lecture (Graz), Medical University Graz, 2012

Plenary Seminar San Raffaele Scientific Institute (Milan), San Raffaele Scientific Institute, Milan, Italy, 2011

Research Staff


Research Student Supervision

Al-Sadah,H, Targeting metabolic vulnerabilities in therapy-resistant solid and haematopoietic cancers

Alasiri,G, The Role of FOXM1 and Endoplasmic Reticulum Stress in Breast Cancer Chemotherapeutic Resistance

Collin,C, Targeting metabolic vulnerabilities in proteostasis-addicted malignancies

Fernando,D, Targeting metabolic vulnerabilities in proteostasis-addicted haematopoietic and solid malignancies

Kuzeva,D, Targeting proteostasis addiction in haematopoietic and solid malignancies

Loaiza,S, The secretory apparatus in osteoblast differentiation and function

Masoudi,N, Fine-tuning of bone health by the proteostasis regulator VCP

Ruiz Tellez,A, Targeting proteostasis addiction in haematopoietic and solid malignancies

Shimada,T, Targeting Metabolic Vulnerabilities in Haematopoietic and Solid Malignancies

Xiong,X, The recovery of multiple myeloma after proteasome inhibition